AVR 1.73% $17.05 anteris technologies ltd

Ann: FIH Results Presented at EuroPCR & Simultaneous Publication, page-3

  1. 2,985 Posts.
    lightbulb Created with Sketch. 1818
    Looks like we have recently operated on another 7 patients successfully in an expansion of the FIH trial. That’s 20 now with 15 to come in the EFS. So by years end we will have a minimum of 35 patients implanted with DurAVR.

    That’s a significant milestone that could be a precursor to a partnership.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.